Risk of malignancy in Thy3 thyroid nodules.

Q3 Medicine
Endocrine regulations Pub Date : 2024-02-12 Print Date: 2023-01-01 DOI:10.2478/enr-2024-0003
Emad Mofid Nassif Rezkallah, Ragai Sobhi Hanna, Wael Magdy Elsaify
{"title":"Risk of malignancy in Thy3 thyroid nodules.","authors":"Emad Mofid Nassif Rezkallah, Ragai Sobhi Hanna, Wael Magdy Elsaify","doi":"10.2478/enr-2024-0003","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective.</b> Thyroid cancer is the most common endocrine malignancy in humans. Ultrasound guided fine needle aspiration cytology (FNAC) is now considered the best diagnostic tool for the evaluation of any thyroid nodule. Thyroid cytology is graded from Thy1 to Thy5 with Thy3 being the most challenging in diagnosis. Our aim was to identify the risk of malignancy in Thy3 cytology in our centre. This risk should be explained to the patient before taking any decision. <b>Methods.</b> One hundred and one patients were included in our study. All patients had Thy3 cytology on preoperative ultrasound scan guided FNAC. All patients had diagnostic hemithyroidectomy. The results from the histology were compared with the cytology findings and the rates of malignancy were identified. <b>Results.</b> Of the 101 patients, 17 were males and 84 females. Average age for diagnosis was 52.4±15 years of age. Patients were classified into three groups; patient who had completely benign histology (n=70), patients who had incidental finding of micro-carcinoma after diagnostic hemithyroidectomy (n=10), and patients who had thyroid macro-carcinomas (n=21). Total rate of malignancy was 30.7% when combining both the malignant and the incidental groups and 20.8% when excluding the incidental group. <b>Conclusion.</b> Our rates of malignancy in Thy3 cytology are similar to the literature. These rates should be explained clearly to the patient during the preoperative counselling. Future advances in biomarkers technology may help to improve the preoperative diagnostic accuracy and reduce the rate of unnecessary thyroid surgery.</p>","PeriodicalId":11650,"journal":{"name":"Endocrine regulations","volume":"58 1","pages":"19-25"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine regulations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/enr-2024-0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective. Thyroid cancer is the most common endocrine malignancy in humans. Ultrasound guided fine needle aspiration cytology (FNAC) is now considered the best diagnostic tool for the evaluation of any thyroid nodule. Thyroid cytology is graded from Thy1 to Thy5 with Thy3 being the most challenging in diagnosis. Our aim was to identify the risk of malignancy in Thy3 cytology in our centre. This risk should be explained to the patient before taking any decision. Methods. One hundred and one patients were included in our study. All patients had Thy3 cytology on preoperative ultrasound scan guided FNAC. All patients had diagnostic hemithyroidectomy. The results from the histology were compared with the cytology findings and the rates of malignancy were identified. Results. Of the 101 patients, 17 were males and 84 females. Average age for diagnosis was 52.4±15 years of age. Patients were classified into three groups; patient who had completely benign histology (n=70), patients who had incidental finding of micro-carcinoma after diagnostic hemithyroidectomy (n=10), and patients who had thyroid macro-carcinomas (n=21). Total rate of malignancy was 30.7% when combining both the malignant and the incidental groups and 20.8% when excluding the incidental group. Conclusion. Our rates of malignancy in Thy3 cytology are similar to the literature. These rates should be explained clearly to the patient during the preoperative counselling. Future advances in biomarkers technology may help to improve the preoperative diagnostic accuracy and reduce the rate of unnecessary thyroid surgery.

Thy3甲状腺结节发生恶性肿瘤的风险。
目的:甲状腺癌是人类最常见的内分泌恶性肿瘤。甲状腺癌是人类最常见的内分泌恶性肿瘤。目前,超声引导下细针穿刺细胞学检查(FNAC)被认为是评估任何甲状腺结节的最佳诊断工具。甲状腺细胞学分级从 Thy1 到 Thy5,其中 Thy3 在诊断中最具挑战性。我们的目的是在本中心确定Thy3细胞学检查的恶性风险。在做出任何决定之前,应向患者解释这种风险。研究方法我们的研究共纳入 101 名患者。所有患者都在术前超声扫描引导下进行了Thy3细胞学FNAC检查。所有患者均接受了诊断性半甲状腺切除术。将组织学检查结果与细胞学检查结果进行比较,并确定恶性率。结果。101 名患者中,17 名男性,84 名女性。平均诊断年龄为(52.4±15)岁。患者分为三组:组织学完全良性的患者(70 人)、诊断性半甲状腺切除术后偶然发现微小癌的患者(10 人)和甲状腺大癌患者(21 人)。如果将恶性组和偶然发现组合并计算,恶性肿瘤的总发生率为30.7%,如果排除偶然发现组,恶性肿瘤的总发生率为20.8%。结论。我们的Thy3细胞学恶性率与文献报道相似。术前咨询时应向患者解释清楚这些恶变率。生物标志物技术的未来发展可能有助于提高术前诊断的准确性,降低不必要的甲状腺手术率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine regulations
Endocrine regulations Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.70
自引率
0.00%
发文量
33
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信